Chicago Equity Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,418	Closed	-$1.32M	–	664
2019 Q4	$1.32M	Sell	21,418 -18,250	-46%	-$1.21M	0.08%	381
2019 Q3	$2.89M	Sell	39,668 -7,800	-16%	-$584K	0.14%	221
2019 Q2	$3.9M	Sell	47,468 -300	-0.6%	-$21.3K	0.17%	154
2019 Q1	$3.37M	Buy	47,768 +615	+1%	+$36.2K	0.13%	221
2018 Q4	$2.12M	Buy	47,153 +7,595	+19%	+$398K	0.09%	326
2018 Q3	$2.24M	Buy	39,558 +1,483	+4%	+$90.8K	0.07%	354
2018 Q2	$2.54M	Buy	38,075 +19,355	+103%	+$1.21M	0.08%	339
2018 Q1	$1.09M	Sell	18,720 -3,850	-17%	-$244K	0.03%	486
2017 Q4	$1.46M	Hold	22,570	–	–	0.04%	429
2017 Q3	$1.19M	Buy	22,570 +2,745	+14%	+$131K	0.04%	481
2017 Q2	$928K	Buy	19,825 +2,465	+14%	+$119K	0.03%	517
2017 Q1	$859K	Buy	17,360 +860	+5%	+$48.3K	0.02%	486
2016 Q4	$1M	Buy	16,500 +4,300	+35%	+$263K	0.03%	462
2016 Q3	$809K	Buy	+12,200	New	+$763K	0.02%	467